申请人:Hoechst-Roussel Pharmaceuticals Incorporated
公开号:US05180834A1
公开(公告)日:1993-01-19
This invention relates to 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5H)-ones and -ols of the formula ##STR1## wherein X is ##STR2## or loweralkyl; Y is hydrogen, halogen, loweralkyl, loweralkoxy, trifluoromethyl, nitro or amino; R is H when the bond between the oxygen atom and the carbon atom in question is a single bond; otherwise the dotted line signifies part of a double bond to the oxygen atom; R.sub.1 is hydrogen, loweralkyl or arylloweralkyl; R.sub.2 and R.sub.3 are independently hydrogen, loweralkyl or arylloweralkyl, or R.sub.2 and R.sub.3 taken together with the nitrogen atom form an optionally substituted heterocycle selected from the group consisting of piperidinyl, pyrrolidinyl, morpholinyl, imidazol-1-yl, 1-piperazinyl, said substituents being hydrogen or loweralkyl;4-substituted-1-piperazinyl of the formula ##STR3## R.sub.8 is hydrogen or --OH; R.sub.4 is hydrogen, loweralkoxycarbonyl or aryloxycarbonyl; Z is chlorine, bromine or fluorine; m is an integer of 1 to 4; n is an integer of 1 to 4 or a pharmaceutically acceptable acid addition salt thereof. The compounds of this invention display utility as antipsychotic agents and analgesic agents.
这项发明涉及式的6,7-二氢-3-苯基-1,2-苯并异噁唑-4(5H)-酮和-醇 ##STR1## 其中X是 ##STR2## 或低烷基; Y是氢、卤素、低烷基、低烷氧基、三氟甲基、硝基或氨基; 当氧原子与所讨论的碳原子之间的键为单键时,R为H; 否则虚线表示与氧原子形成双键的一部分; R.sub.1是氢、低烷基或芳基低烷基; R.sub.2和R.sub.3独立地是氢、低烷基或芳基低烷基,或者R.sub.2和R.sub.3与氮原子一起形成从吡哌啉基、吡咯啉基、吗啉基、咪唑-1-基、1-哌嗪基中选取的可选择取代的杂环,所述取代基为氢或低烷基;式的4-取代-1-哌嗪基 ##STR3## R.sub.8是氢或--OH; R.sub.4是氢、低烷氧羰基或芳氧羰基; Z是氯、溴或氟; m是1到4的整数; n是1到4的整数或其药学上可接受的酸盐。本发明的化合物显示出作为抗精神病药物和镇痛药物的效用。